Blue Lizard Australian Sunscreen has partnered with the Chicago Cubs and New York Yankees to fight skin cancer as the teams official sunscreen. This winter, the Blue Lizard mascot trekked across frozen Chicago and slushy Manhattan napping ...
Tags: Sunscreen, photos, Recreation
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
ANI Pharmaceuticals Inc., an emerging generic pharmaceutical company, has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services ("Sterling"). The product will be developed by ...
Tags: ANI Pharmaceuticals Inc, pharmaceutical company, Sterling
Actavis plc (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a ...
Today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal ...
Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation AMITYVILLE, N.Y., December 26, 2013--(BUSINESS WIRE)--Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today announced that the Texas Attorney General has agreed to ...
Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of Octreotide Acetate Injection, a Somatostatin Analog, in five vial presentations. According to IMS, for the 12 months ending October 2013, the US market for Octreotide ...
Biodel, a specialty pharmaceutical company, has announced a long-term supply agreement with Becton, Dickinson and Company, a medical technology company, for worldwide exclusive rights to the novel and proprietary BD Uniject SCF disposable ...
Tags: Biodel, Rescue Device
QRxPharma, an Australian-based commercial-stage specialty pharmaceutical company, has resubmitted its MOXDUO new drug application (NDA). At a meeting in early October 2013, the US Food and Drug Administration (FDA) provided QRxPharma with ...
Tags: QRxPharma, Drug Application
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Collegium Pharmaceutical, a specialty pharmaceutical company, has announced that a patent has been issued by the US Patent and Trademark Office (USPTO) covering its Oxycodone DETERx formulation. Additionally, an application has been ...
Specialty pharmaceutical company Supernus has launched Trokendi XR, its once-daily extended release formulation of topiramate, for the treatment of epilepsy in the US. As of now, Trokendi XR has been shipped to major wholesalers in the ...
Valeant Pharmaceuticals International has closed the acquisition of Bausch + Lomb Holdings, a US-based manufacturer of eye health products, for $8.7bn. Bausch + Lomb Holdings has a broad portfolio of eye health products, including OTC ...
Tags: Valeant Pharmaceuticals
Global packaging company MeadWestvaco (MWV) has introduced a new discreet medication adherence package, Shellpak Renew with Optilock technology. Designed to address the needs of patient and pharmacist by enabling patient portability and ...
Tags: MWV, Adherence Package